A. Cilibrizzi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A Cilibrizzi, Agostino Cilibrizzi
Publication record
88 papers · 1,217 citations · H-index 20

PAPERS

Engineered α‐Helical Peptides with Chelating Agents as Approach to Antibacterial Therapeutics
20260 citationsauthor #7
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors
20250 citationsauthor #2
New Heterocyclic A1/A3 Adenosine Receptor Ligands through Molecular Simplification Strategies
20251 citationsauthor #14
Coprogen B from Talaromyces marneffei ΔsreA: Rapid Iron Chelation and Favorable Partitioning to Deferoxamine
20250 citationsauthor #6
Drug Susceptibility, Siderophore Production, and Genome Analysis of Staphylococcus aureus Clinical Isolates from a University Hospital in Chiang Mai, Thailand
20250 citationsauthor #7
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?
20250 citationsauthor #4
Main Mechanical Forces to Analyse the Chemical Interactions Shaping Backbone Torsion Angles in DNA Tertiary Structures
20250 citationsauthor #4
Development of small-molecule fluorescent probes targeting neutrophils via N-formyl peptide receptors
20252 citationsauthor #6
‘Main Mechanical Forces‐Chemical Interactions’ Interplay as a Tool to Elucidate Folding Mechanisms
20243 citationsauthor #4
Beyond transition block metals: exploring the reactivity of phosphine PTA and its oxide [PTA(O)] towards gallium(iii)
20241 citationsauthor #4
[68Ga]Ga-Schizokinen, a Potential Radiotracer for Selective Bacterial Infection Imaging
20245 citationsauthor #6
Dominant Chemical Interactions Governing the Folding Mechanism of Oligopeptides
20243 citationsauthor #4
The iron(III) coordinating properties of citrate and α-hydroxycarboxylate containing siderophores.
20245 citationsauthor #3
Non-salt based Co-amorphous Formulation produced by Freeze-drying.
20232 citationsauthor #5
Evaluating Thermogravimetric Analysis for the Measurement of Drug Loading in Mesoporous Silica Nanoparticles (MSNs)
202329 citationsauthor #5
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors
20231 citationsauthor #8
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration
20232 citationsauthor #6
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors
202312 citationsauthor #5
The Colorimetric Detection of the Hydroxyl Radical
20236 citationsauthor #4
Optical Imaging Opportunities to Inspect the Nature of Cytosolic Iron Pools
20236 citationsauthor #4
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes
202326 citationsauthor #5
Editorial: Serine protease inhibitors and their therapeutic applications
20221 citationsauthor #3
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets
20224 citationsauthor #9
Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments
20220 citationsauthor #4
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition
20227 citationsauthor #9
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes
20227 citationsauthor #8
PSMA-targeted NIR probes for image-guided detection of prostate cancer.
202214 citationsauthor #1
The synthesis and properties of mitochondrial targeted iron chelators
202210 citationsauthor #1
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
202295 citationsauthor #3
Effect of iron chelation on anti-pseudomonal activity of doxycycline
202123 citationsauthor #2
Corrigendum to "Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives" [Bioorganic Med. Chem. Lett. 42 (2021) 128044].
20211 citationsauthor #6
Dipeptide Inhibitors of the Prostate Specific Membrane Antigen (PSMA): A Comparison of Urea and Thiourea Derivatives.
20218 citationsauthor #6
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N‐formyl peptide receptors agonists
20218 citationsauthor #8
Principles that rule the calculation of dihedral angles in secondary structures: the cases of an α-helix and a β-sheet
20214 citationsauthor #3
Human telomere double G-quadruplex recognition by berberine-bisquinolinium imaging conjugates in vitro and cells.
202016 citationsauthor #4
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening
20207 citationsauthor #5
Pharmacokinetics of Mephedrone Enantiomers in Whole Blood after a Controlled Intranasal Administration to Healthy Human Volunteers
202013 citationsauthor #3
Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents.
202019 citationsauthor #7
Glutathione and the intracellular labile heme pool
202016 citationsauthor #5
Solid-Phase Synthesis and In-Silico Analysis of Iron-Binding Catecholato Chelators
20202 citationsauthor #3
Illuminating the path to target GPCR structures and functions.
20204 citationsauthor #5
Synthetic Approaches for Piperidone-Based Templates as Scaffolds to Access Chirally Enriched Donepezil Analogues
20204 citationsauthor #4
Dihedral Angle Calculations To Elucidate the Folding of Peptides through Its Main Mechanical Forces.
20197 citationsauthor #3
The cytoprotective potential of mitochondria-targeted iron chelators against H2O2-mediated toxicity in Friedreich’s ataxia fibroblasts
20190 citationsauthor #3
Synthesis and iron coordination properties of schizokinen and its imide derivative.
20195 citationsauthor #5
Measurement of Bile Acids as a Marker of the Functionality of iPSC-Derived Hepatocytes.
20190 citationsauthor #3
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation.
201936 citationsauthor #2
The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8mt00257f
201914 citationsauthor #3
Curcumin and Neglected Infectious Diseases
20191 citationsauthor #2
New Biological Targets for the Treatment of Leishmaniasis
20193 citationsauthor #5
Mass Spectrometry Measurement of Albumin-Alpha Fetoprotein Ratio as an Indicator of iPSC-Derived Hepatocyte Differentiation.
20191 citationsauthor #3
Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
20187 citationsauthor #1
A case of extensive protein platination: the reaction of lysozyme with a Pt(ii)-terpyridine complex.
201812 citationsauthor #4
Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites.
201813 citationsauthor #6
iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer
20186 citationsauthor #1
Analytical characterization of three cathinone derivatives, 4-MPD, 4F-PHP and bk-EPDP, purchased as bulk powder from online vendors.
201827 citationsauthor #5
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
201826 citationsauthor #2
Hydroxypyridinone Journey into Metal Chelation.
201870 citationsauthor #1
Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
20180 citationsauthor #1
Small-molecule optical probes for cell imaging of protein sulfenylation and their application to monitor cisplatin induced protein oxidation
20175 citationsauthor #1
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors
201713 citationsauthor #3
Synthesis of Five‐ and Six‐Membered N‐Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists
20179 citationsauthor #4
A tri-functional vanadium(iv) complex to detect cysteine oxidation.
20173 citationsauthor #1
A lipophilic copper(ii) complex as an optical probe for intracellular detection of NO.
20168 citationsauthor #3
Vanadyl complexes with dansyl-labelled di-picolinic acid ligands: synthesis, phosphatase inhibition activity and cellular uptake studies.
20165 citationsauthor #2
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.
201621 citationsauthor #4
Cinnoline derivatives as human neutrophil elastase inhibitors
201637 citationsauthor #5
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists.
201520 citationsauthor #3
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents.
201512 citationsauthor #3
Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.
201451 citationsauthor #5
New vanadium complexes as optical probes to detect Cys sulfenic modifications in PTEN
20140 citationsauthor #1
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.
201347 citationsauthor #3
Synthesis and Pharmacological Evaluation of New Pyridazin‐Based Thioderivatives as Formyl Peptide Receptor (FPR) Agonists
201323 citationsauthor #3
Synthesis, HPLC enantioresolution, and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists.
201312 citationsauthor #1
Synthesis and Evaluation as Antitubercular Agents of 5‐Arylethenyl and 5‐(Hetero)aryl‐3‐Isoxazolecarboxylate
20135 citationsauthor #2
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.
201341 citationsauthor #3
Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists.
201232 citationsauthor #1
New Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones Fluoroderivatives as Human A1 Adenosine Receptor Ligands.
20124 citationsauthor #3
Novel Phosphate Derivativesas Scaffolds for the Preparation of Synthetic Phosphoserine-BasedPeptides Using the Fmoc/t-BuSolid-Phase Strategy
20121 citationsauthor #1
Synthesis and evaluation as PDE4 inhibitors of pyrimidine‐2,4‐dione derivatives
20113 citationsauthor #9
Diversity-oriented synthesis of macrocyclic peptidomimetics
2011101 citationsauthor #4
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.
201127 citationsauthor #6
Diversity-oriented synthesis of macrocyclic
20110 citationsauthor #3
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
201018 citationsauthor #3
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.
201027 citationsauthor #6
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.
200940 citationsauthor #7
6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.
200959 citationsauthor #1
Synthesis and Evaluation of Novel Pyrrolo [2,3-d] and Thieno[2,3-d]Pyridazinones as in Vitro Antiproliferative Agents
20092 citationsauthor #5

TIMELINE

2009 101 citations

2010 45 citations

2011 131 citations

2012 37 citations

2013 128 citations

2014 51 citations

2015 32 citations

2016 71 citations

2017 30 citations

2018 161 citations

2019 67 citations

2020 81 citations

2021 44 citations

2022 138 citations

2023 84 citations

2024 17 citations

2025 3 citations

2026 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT